Table 2.
Mechanical ventilation (MV) parameters and clinical information associated with the usage of cisatracurium.
| Intervals between initiation of MV and muscle relaxation | 48 hours |
|---|---|
| APACHE II scores (24 h after NMB drug administration) | 26 |
| PaO2/FiO2 ratio median (IQR) | 147 (117–307) mmHg |
| Vt median (IQR) | 370 (350–460) mL |
| PaO2 median (IQR) | 81 (69–177) mmHg |
| PaCO2 median (IQR) | 43 (34.9–61.7) mmHg |
| PetCO2 median (IQR) | 33 (28–48) mmHg |
| Respiratory Rate (RR) median (IQR) | 22 (18-26) |
| Pplat median (IQR) | 24 (23–29) cmH2O |
| PEEP median (IQR) | 6 (5–8) cmH2O |
| FiO2 median (IQR) | 50 (45–70) % |
| Blood Glucose (arterial blood) median (IQR) | 7.8 (5–15.5) mmol/L |
| Midazolam, median (IQR) | 3.43 (2.06–6.17) mg/kg.d |
| Remifentanil, median (IQR) | 3.79 (3.43–8.57) μg/kg.h |
| Cisatracurium Besilate, median (IQR) | 1.91 (1.43–9.52) μg/kg.min |
| Data collected from February 8th, 2021 to March 9th, 2021 | |
| IQR: interquartile range | |